| 摘要 |
In view of the discovery that D-carnitine exhibits an antagonistic effect versus the therapeutically adantageous effect of L-carnitine on free fatty acid levels, a pharmaceutical composition is described for the treatment of hyperlipidaemias and hyperlipoproteinaemias, characterized by the fact that all the carnitine present therein is solely L-carnitine.
|
